Czechia Pharmaceutical and Medical Goods Expenditure Share (2023)
Czechia's Pharmaceutical and Medical Goods Expenditure Share: 16.2 % of current health expenditure in 2023, +0.1pp YoY.
Czechia (2023)
16.2
% of current health expenditure
+0.1pp YoY
YoY Change
+0.1pp
percentage points
Trend
up
Series length
8
years of data
Data
| Year | % of current health expenditure | YoY Change |
|---|---|---|
| 2023 | 16.2 | +0.1pp |
| 2022 | 16.1 | +0.4pp |
| 2021 | 15.7 | -1.9pp |
| 2020 | 17.6 | -0.7pp |
| 2019 | 18.3 | -0.6pp |
| 2018 | 18.9 | -0.8pp |
| 2017 | 19.7 | -0.7pp |
| 2016 | 20.4 | n/a |
About this Dataset
Czechia recorded 16.2 % of current health expenditure in 2023. The latest change was +0.1pp. Across 2016–2023 the series ranges from 15.7 in 2021 to 20.4 in 2016.
This page tracks the share of current health expenditure devoted to pharmaceuticals and medical goods in Czechia.
Data sourced from Eurostat via SDMX REST API. Values use harmonised methodology intended for cross-country comparison.
Frequently Asked Questions
This page tracks the share of current health expenditure devoted to pharmaceuticals and medical goods in Czechia. It is published by Eurostat and updated annually.
The most recent observation covers 2023. Eurostat typically publishes this series with a lag of several months after the reference period. The series runs 2016–2023 (8 observations).
The series peaked at 20.4 % of current health expenditure in 2016 and reached its lowest recorded value of 15.7 in 2021. The latest reading of 16.2 in 2023 represents a change of +0.1pp.